Novartis AG (NVSN) — Cash Flow Quality Index
Novartis AG (NVSN) has a Cash Flow Quality Index of 1.16x as of March 2026. Operating cash flow of MX$3.68 Billion exceeds net income of MX$3.16 Billion, indicating high earnings quality where cash backs reported profits. Explore NVSN cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Novartis AG Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for Novartis AG across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Novartis AG total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Novartis AG (2014–2025)
Year-by-year earnings quality comparison for Novartis AG. For live market cap and the full company financial profile, see Novartis AG market cap and net worth.
| Year | Quality Index | Operating CF (MXN) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.37x | MX$19.14 Billion | MX$13.98 Billion | ▼ -7.2% |
| 2024 | 1.48x | MX$17.62 Billion | MX$11.94 Billion | ▲ +36.8% |
| 2023 | 1.08x | MX$16.02 Billion | MX$14.85 Billion | ▼ -47.3% |
| 2022 | 2.05x | MX$14.24 Billion | MX$6.96 Billion | ▲ +226.2% |
| 2021 | 0.63x | MX$15.07 Billion | MX$24.02 Billion | ▼ -62.9% |
| 2020 | 1.69x | MX$13.65 Billion | MX$8.07 Billion | ▲ +45.6% |
| 2019 | 1.16x | MX$13.62 Billion | MX$11.73 Billion | ▲ +2.6% |
| 2018 | 1.13x | MX$14.27 Billion | MX$12.61 Billion | ▼ -30.9% |
| 2017 | 1.64x | MX$12.62 Billion | MX$7.70 Billion | ▼ -4.2% |
| 2016 | 1.71x | MX$11.47 Billion | MX$6.71 Billion | ▲ +155.5% |
| 2015 | 0.67x | MX$11.90 Billion | MX$17.78 Billion | ▼ -50.8% |
| 2014 | 1.36x | MX$13.90 Billion | MX$10.21 Billion | — |